Literature DB >> 29773869

Accurate diagnosis of diabetes mellitus and new paradigms of classification.

Sudesna Chatterjee1, Melanie J Davies2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29773869     DOI： 10.1038/s41574-018-0025-1

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  5 in total

1.  Regulatory effect of chemerin and therapeutic efficacy of chemerin‑9 in pancreatogenic diabetes mellitus.

Authors:  Jianfeng Tu; Yue Yang; Jingzhu Zhang; Guotao Lu; Lu Ke; Zhihui Tong; Maimaitijiang Kasimu; Dejun Hu; Qiuran Xu; Weiqin Li
Journal:  Mol Med Rep       Date:  2020-01-08       Impact factor: 2.952

Review 2.  Anti-obesity drug discovery: advances and challenges.

Authors:  Timo D Müller; Matthias Blüher; Matthias H Tschöp; Richard D DiMarchi
Journal:  Nat Rev Drug Discov       Date:  2021-11-23       Impact factor: 112.288

3.  Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan.

Authors:  Kohei Saito; Tatsuhide Inoue; Hiroyuki Ariyasu; Toshio Shimada; Hiroshi Itoh; Issei Tanaka; Chikashi Terao
Journal:  J Diabetes Investig       Date:  2021-12-07       Impact factor: 3.681

4.  Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: A two-step cluster analysis.

Authors:  Xiao-Fen Xiong; Yuan Yang; Ling Wei; Ying Xiao; Li Li; Lin Sun
Journal:  J Diabetes Investig       Date:  2021-02-14       Impact factor: 4.232

5.  PDX1 and MC4R genetic polymorphisms are associated with type 2 diabetes mellitus risk in the Chinese Han population.

Authors:  Ning Wang; Rui Tong; Jing Xu; Yanni Tian; Juan Pan; Jiaqi Cui; Huan Chen; Yanqi Peng; Sijia Fei; Shujun Yang; Lu Wang; Juanchuan Yao; Wei Cui
Journal:  BMC Med Genomics       Date:  2021-10-25       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.